glp-1 receptor agonists benefits in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Benefits and drawbacks of GLP-1
Description
Furthermore, the hydroxyl group on the adamantyl molecule forms hydrogen bonds with Ser209 and Tyr547
Ali Z, Akhtar MJ, Siddiqui AA, Khan AA, Haider MR, Yar MS
The addition of insulin, which usually acts as a vasodilatory agent, did not increase MBV or MBF compared with GLP-1 alone, which suggests the presence of microvascular insulin resistance and the insulin-independent effects of GLP-1 on cardiac microvasculature
P =0.682)
For all-cause mortality, the survival probabilities were 86.3% with GLP-1RA use and 88.9% with SGLT2 inhibitors at five years
JAMA Network
